AAAAAA

   
Results: 1-12 |
Results: 12
Moderation of iodoacetate-induced experimental osteoarthritis in rats by matrix metalloproteinase inhibitors
Authors: Janusz, MJ Hookfin, EB Heitmeyer, SA Woessner, JF Freemont, AJ Hoyland, JA Brown, KK Hsieh, LC Almstead, NG De, B Natchus, MG Pikul, S Taiwo, YO
Citation: Mj. Janusz et al., Moderation of iodoacetate-induced experimental osteoarthritis in rats by matrix metalloproteinase inhibitors, OSTEO CART, 9(8), 2001, pp. 751-760
The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity
Authors: Staudinger, JL Goodwin, B Jones, SA Hawkins-Brown, D MacKenzie, KI Latour, A Liu, YP Klaassen, CD Brown, KK Reinhard, J Willson, TN Koller, BH Kliewer, SA
Citation: Jl. Staudinger et al., The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity, P NAS US, 98(6), 2001, pp. 3369-3374
Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists
Authors: Way, JM Gorgun, CZ Tong, Q Uysal, KT Brown, KK Harrington, WW Oliver, WR Willson, TM Kliewer, SA Hotamisligil, GS
Citation: Jm. Way et al., Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists, J BIOL CHEM, 276(28), 2001, pp. 25651-25653
Comprehensive messenger ribonucleic acid profiling reveals that peroxisomeproliferator-activated receptor gamma activation has coordinate effects ongene expression in multiple insulin-sensitive tissues
Authors: Way, JM Harrington, WW Brown, KK Gottschalk, WK Sundseth, SS Mansfield, TA Ramachandran, RK Willson, TM Kliewer, SA
Citation: Jm. Way et al., Comprehensive messenger ribonucleic acid profiling reveals that peroxisomeproliferator-activated receptor gamma activation has coordinate effects ongene expression in multiple insulin-sensitive tissues, ENDOCRINOL, 142(3), 2001, pp. 1269-1277
Mitochondrial disease - A pulmonary and critical-care medicine perspective
Authors: Clay, AS Behnia, M Brown, KK
Citation: As. Clay et al., Mitochondrial disease - A pulmonary and critical-care medicine perspective, CHEST, 120(2), 2001, pp. 634
Small vessel vasculitis of the lung
Authors: Schwarz, MI Brown, KK
Citation: Mi. Schwarz et Kk. Brown, Small vessel vasculitis of the lung, THORAX, 55(6), 2000, pp. 502-510
Acute interstitial pneumonitis - Case series and review of the literature
Authors: Vourlekis, JS Brown, KK Cool, CD Young, DA Cherniack, RM King, TE Schwarz, MI
Citation: Js. Vourlekis et al., Acute interstitial pneumonitis - Case series and review of the literature, MEDICINE, 79(6), 2000, pp. 369-378
Role of p38 mitogen-activated protein kinase in a murine model of pulmonary inflammation
Authors: Nick, JA Young, SK Brown, KK Avdi, NJ Arndt, PG Suratt, BT Janes, MS Henson, PM Worthen, GS
Citation: Ja. Nick et al., Role of p38 mitogen-activated protein kinase in a murine model of pulmonary inflammation, J IMMUNOL, 164(4), 2000, pp. 2151-2159
Peroxisome proliferator-activate inhibit development of atherosclerosis inLDL receptor-deficient mice
Authors: Li, AC Brown, KK Silvestre, MJ Willson, TM Palinski, W Glass, CK
Citation: Ac. Li et al., Peroxisome proliferator-activate inhibit development of atherosclerosis inLDL receptor-deficient mice, J CLIN INV, 106(4), 2000, pp. 523-531
A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat
Authors: Brown, KK Henke, BR Blanchard, SG Cobb, JE Mook, R Kaldor, I Kliewer, SA Lehmann, JM Lenhard, JM Harrington, WW Novak, PJ Faison, W Binz, JG Hashim, MA Oliver, WO Brown, HR Parks, DJ Plunket, KD Tong, WQ Menius, JA Adkison, K Noble, SA Willson, TM
Citation: Kk. Brown et al., A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat, DIABETES, 48(7), 1999, pp. 1415-1424
N-(2-benzoylphenyl)-L-tyrosine PPAR gamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents
Authors: Henke, BR Blanchard, SG Brackeen, MF Brown, KK Cobb, JE Collins, JL Harrington, WW Hashim, MA Hull-Ryde, EA Kaldor, I Kliewer, SA Lake, DH Leesnitzer, LM Lehmann, JM Lenhard, JM Orband-Miller, LA Miller, JF Mook, RA Noble, SA Oliver, W Parks, DJ Plunket, KD Szewczyk, JR Willson, TM
Citation: Br. Henke et al., N-(2-benzoylphenyl)-L-tyrosine PPAR gamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents, J MED CHEM, 41(25), 1998, pp. 5020-5036
N-(2-benzoylphenyl)-L-tyrosine PPAR gamma agonists. 3. Structure-activity relationship and optimization of the N-aryl substituent
Authors: Cobb, JE Blanchard, SG Boswell, EG Brown, KK Charifson, PS Cooper, JP Collins, JL Dezube, M Henke, BR Hull-Ryde, EA Lake, DH Lenhard, JM Oliver, W Oplinger, J Pentti, M Parks, DJ Plunket, KD Tong, WQ
Citation: Je. Cobb et al., N-(2-benzoylphenyl)-L-tyrosine PPAR gamma agonists. 3. Structure-activity relationship and optimization of the N-aryl substituent, J MED CHEM, 41(25), 1998, pp. 5055-5069
Risultati: 1-12 |